view counter
 
view counter
 
 

New Clenbuterol Rules Now In Effect

Published: August 25, 2015 4:19 pm ET

Last Comment: August 25, 2015 7:43 pm ET | 1 Comment(s) | Jump to Comments

The Canadian Pari-Mutuel Agency has issued an important reminder to the Canadian horse racing industry that a significant change to the elimination guideline for Clenbuterol will come into effect September 1. The change states that the current elimination guideline for Clenbuterol will be increased from 72 hours to 168 hours (seven days).

The main points from the CPMA’s changes to the elimination guidelines are as follows:

  1. The current elimination guideline for the 0.40 mg oral dose given twice daily for 5 days of clenbuterol (Ventipulmin) contained in the 2011 edition of the Schedule of Drugs booklet will be increased from 72 hours to 168 hours (7 days).

  2. CPMA is temporarily removing the elimination guideline for the 0.30 mg intravenous single administration until further studies are completed.

  3. The 0.32 mg oral single administration will no longer have an elimination guideline.

To view a copy of the CPMA’s memorandum, click here.

The CPMA has announced that the changes will come into effect on September 1, 2015.

The contents of the memorandum appear below.


This memo is to inform the horse racing industry of upcoming changes to the elimination guidelines for CLENBUTEROL.

Specifically:

  1. The current elimination guideline for the 0.40 mg oral dose given twice daily for 5 days of clenbuterol (Ventipulmin) contained in the 2011 edition of the Schedule of Drugs booklet will be increased from 72 hours to 168 hours (7 days).

  2. CPMA is temporarily removing the elimination guideline for the 0.30 mg intravenous single administration until further studies are completed.

  3. The 0.32 mg oral single administration will no longer have an elimination guideline.

There are several medications that may be used as alternatives for clenbuterol. The CPMA provides elimination guideline for some of these substances in the 2011 Schedule of Drugs.

To allow ample time for the industry to adjust to the new elimination guidelines, these changes will come into effect on September 1, 2015 and will be reflected in the next version of the Schedule of Drugs booklet expected to be released later this year.

As always, the CPMA recommends that owners and trainers consult their own veterinarian for advice and guidance in the use of all drugs.


La présente vise à informer l’industrie des courses de chevaux de la modification des lignes directrices d’élimination du CLENBUTEROL.

Plus précisément :

  1. La ligne directrice d’élimination actuelle pour la dose orale de 0,40 mg de clenbuterol (Ventipulmin) donnée deux fois par jour pendant cinq jours indiqué dans l’Annexe des drogues 2011 (brochure) passera de 72 heures à 168 heures (sept jours).

  2. L’ACPM supprime temporairement la ligne directrice d’élimination pour la dose unique de 0,30 mg par intraveineuse jusqu’à ce que plus d’études soient complétées.

  3. La dose orale unique de 0,32 mg ne sera plus assortie d’une ligne directrice d’élimination.

Plusieurs médicaments peuvent être utilisés à la place du clenbuterol. L’ACPM fournit des lignes directrices d’élimination pour certaines de ces substances dans l’Annexe des drogues de 2011.

Afin que l’industrie ait le temps de s’adapter aux nouvelles directives d’élimination, les modifications susmentionnées prendront effet le 1er septembre 2015 et seront incluses dans la prochaine version de l’Annexe des drogues, qui devrait être publiée plus tard cette année.

Comme toujours, l’ACPM recommande que les propriétaires et les entraîneurs consultent leur vétérinaire pour se faire conseiller sur l’utilisation de toutes les drogues.


August 25, 2015 - 7:43 pmI can't help but wonder why

Ted Decker SAID...

I can't help but wonder why the industry is using a 2011 version of the schedule of drugs. What year is this?


view counter
 
 
 

© 2019 Standardbred Canada. All rights reserved. Use of this site signifies your agreement and compliance with the legal disclaimer and privacy policy.

Firefox 3 Best with IE 7 Built with Drupal